MAPT and Alzheimer disease: Using immunohistochemistry, SCRN-1 has been found to be present in plaque-associated dystrophic neurites (142), and a TMS study showed increased CSF SCRN-1 concentrations in AD patients compared with controls (143), and a strong correlation to CSF tau concentration.